Search results

Read about an ANSTO scientist and their work to prepare for a school project or interview.

ANSTO is participating in a major project to learn more about an important component of the atmosphere, the hydroxyl radical.

Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.

Publications and resources from the Powder Diffraction beamline.

The Infrared microspectroscopy microscopes can record spectra from a range of different samples; from thin microtomed sections to polished blocks and embedded particles. This section highlights the types of samples that can be analysed using the IRM beamline

ANSTO is an experienced provider of Teacher Professional Development for Australian and International teachers and our courses cover a wide range of topics. Hear from expert speakers, receive new education resources, and develop lessons for your own class.

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.

See details of previously published customer updates from our Health products team. 

Publications by ANSTO's National Deuteration Facility.

The BRIGHT Nanoprobe beamline provides a unique facility capable of spectroscopic and full-field imaging. NANO will undertake high-resolution elemental mapping and ptychographic coherent diffraction imaging. Elemental mapping and XANES studies (after DCM upgrade) will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using ptychography.

Highlights of the Energy Materials Project.

Latest information on the scheduled supply of our nuclear medicine production.